KING OF PRUSSIA, Pa., July 17, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2023, after the market closes on Tuesday, July 25, 2023. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Wednesday, July 26, 2023
A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.
Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.
| Last Trade: | US$204.31 |
| Daily Change: | -3.19 -1.54 |
| Daily Volume: | 972,746 |
| Market Cap: | US$12.150B |
October 29, 2024 June 07, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
